| 3MY5 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | FMT, RFZ, SGM, TPO | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Halogen bonds form the basis for selective P-TEFb inhibition by DRB., Baumli S, Endicott JA, Johnson LN, Chem Biol. 2010 Sep 24;17(9):931-6. PMID:20851342 | ||||||||||||||
| Data retrieval |
![]() |
| View 3MY5 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |